Biblio

Author Title [ Type

] Year

Filters: Author is Jol-van der Zijde, Cornelia M [Clear All Filters]

Journal Article

Oostenbrink LVE, von Asmuth EGJ, van der Zijde CMJol-, Jansen-Hoogendijk AM, Vervat C, Bredius RGM, van Tol MJD, Schilham MW, Sedlacek P, Ifversen M, et al. Anti-T-lymphocyte globulin exposure is associated with acute graft-versus-host disease and relapse in pediatric acute lymphoblastic leukemia patients undergoing hematopoietic stem cell transplantation: a multinational prospective study. Haematologica. 2024.

Admiraal R, van Kesteren C, van der Zijde CMJol-, Lankester AC, Bierings MB, Egberts TCG, van Tol MJD, Knibbe CAJ, Bredius RGM, Boelens JJ. Association between anti-thymocyte globulin exposure and CD4+ immune reconstitution in paediatric haemopoietic cell transplantation: a multicentre, retrospective pharmacodynamic cohort analysis. Lancet Haematol. 2015;2(5):e194-203.

Lugthart G, Jordans CCE, de Pagter APJ, Bresters D, van der Zijde CMJol-, Bense JE, van Rooij-Kouwenhoven RWG, Sukhai RN, Louwerens M, Dorresteijn EM, et al. Chronic kidney disease ten years after pediatric allogeneic hematopoietic stem cell transplantation. Kidney Int. 2021.

Achini-Gutzwiller FR, van der Zijde CMJol-, Jansen-Hoogendijk AM, Lankester AC, Bredius RGM, van Tol MJD, Moes DJan AR, Schilham MW. Development and Validation of an Efficient and Highly Sensitive ELISA for Alemtuzumab Quantification in Human Serum and Plasma. Ther Drug Monit. 2022.

Lugthart G, Oomen MA, van der Zijde CMJol-, Ball LM, Bresters D, Kollen WJW, Smiers FJ, Vermont CL, Bredius RGM, Schilham MW, et al. The effect of cidofovir on adenovirus plasma DNA levels in stem cell transplantation recipients without T cell reconstitution. Biol Blood Marrow Transplant. 2014.

Willemsen L, van der Zijde CMJol-, Admiraal R, Putter H, Jansen-Hoogendijk AM, Dam MMOstaijen, Wijnen JT, van Kesteren C, Waaijer JLM, Lankester AC, et al. Impact of serotherapy on immune reconstitution and survival outcomes after stem cell transplantations in children: thymoglobulin versus alemtuzumab. Biol Blood Marrow Transplant. 2014.

Verhoeven DHJ, Claas ECJ, van der Zijde CMJol-, Thijssen JCP, Lankester AC, Bredius RGM, Putter H, Kroes ACM, R Egeler M, Schilham MW, et al. Reactivation of Human Herpes Virus-6 after Pediatric Stem Cell Transplantation: Risk Factors, Onset, Clinical Symptoms and Association with Severity of Acute Graft-Versus-Host Disease. Pediatr Infect Dis J. 2015.